Topic Hub
14 clinically reviewed articles, written and peer-reviewed by the HealthRX.com Medical Team.
Explore
Showing 14 of 14 clinical reviews.
A clinician-reviewed guide covering how older adults on Repatha (evolocumab) can safely maintain physical activity, community programs, and daily routines, with dosing, monitoring, and exercise interaction data.
Read clinical reviewA comprehensive clinical review of how evolocumab (Repatha) affects growth, puberty, hormones, bone, and neurodevelopment in adolescents ages 12 to 17, with trial data, dosing guidance, and monitoring protocols.
Read clinical reviewA clinical review of off-label evolocumab (Repatha) use in adolescents ages 12 to 17, covering trial data, dosing, safety, and guideline recommendations for pediatric familial hypercholesterolemia.
Read clinical reviewA clinician-reviewed guide to managing Repatha (evolocumab) therapy in adolescents ages 12 to 17, covering school accommodations, injection timing, sports participation, and activity safety.
Read clinical reviewA clinical guide to transitioning adolescents on Repatha (evolocumab) to adult cardiovascular care, covering dose continuity, monitoring, and shared decision-making for patients with familial hypercholesterolemia.
Read clinical reviewA clinical deep-dive into how evolocumab (Repatha) performs in patients aged 65 and older, covering LDL reduction, cardiovascular outcomes, safety signals, dosing considerations, and what geriatric physiology means for long-term PCSK9 inhibitor therapy.
Read clinical reviewA clinician-reviewed guide to evolocumab (Repatha) use in geriatric patients aged 65+, covering trial evidence, dosing, safety, drug interactions, and practical decision-making for older adults with elevated LDL-C.
Read clinical reviewA physician-reviewed guide to evolocumab (Repatha) use in pediatric patients under age 12, covering developmental safety data, FDA approval status, cholesterol biology in children, and clinical trial evidence.
Read clinical reviewA clinical guide to transitioning pediatric patients (under age 12 at diagnosis) on evolocumab to adult lipid-management care, covering dosing, monitoring, handoff timing, and what families should expect.
Read clinical reviewA clinician-reviewed guide for parents and school nurses on managing evolocumab (Repatha) therapy in children under 12, covering injection schedules, PE participation, injection site care, and communication with school staff.
Read clinical reviewA clinical guide for geriatric patients and providers managing evolocumab (Repatha) therapy at age 65+, covering dosing, safety, LDL targets, Medicare coverage, and care-transition checkpoints.
Read clinical reviewA clinician-focused review of evolocumab (Repatha) off-label use in children younger than 12, covering the evidence base, dosing considerations, safety data, and current guideline positions.
Read clinical reviewComplete caregiver guide for administering Repatha (evolocumab) to adults aged 65 and older: injection technique, storage, missed doses, monitoring, and when to call the prescriber.
Read clinical reviewStep-by-step caregiver guidance for administering Repatha (evolocumab) to children under 12, including approved indications, dosing, injection technique, storage, and safety monitoring.
Read clinical review